| Literature DB >> 34936860 |
Michael Morgan1, Tatsuya Ikenoue2, Hiroaki Suga3, Cynthia Wolberger4.
Abstract
The Spt-Ada-Gcn5 acetyltransferase (SAGA) transcriptional coactivator contains a four-protein subcomplex called the deubiquitinating enzyme (DUB) module that removes ubiquitin from histone H2B-K120. The human DUB module contains the catalytic subunit ubiquitin-specific protease 22 (USP22), which is overexpressed in a number of cancers that are resistant to available therapies. We screened a massive combinatorial library of cyclic peptides and identified potent inhibitors of USP22. The top hit was highly specific for USP22 compared with a panel of 44 other human DUBs. Cells treated with peptide had increased levels of H2B monoubiquitination, demonstrating the ability of the cyclic peptides to enter human cells and inhibit H2B deubiquitination. These macrocycle inhibitors are, to our knowledge, the first reported inhibitors of USP22/SAGA DUB module and show promise for development.Entities:
Keywords: USP22; chromatin; deubiquitinating enzyme; drug discovery; macrocyclic peptides; transcription; ubiquitin
Mesh:
Substances:
Year: 2021 PMID: 34936860 PMCID: PMC9035043 DOI: 10.1016/j.chembiol.2021.12.004
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 9.039